OrthoPediatrics Corp. (KIDS)
NGM – Real vaqt narxi. Valyuta: USD
17.72
+0.54 (3.14%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
17.72
+0.54 (3.14%)
Yopilishda: May 12, 2026, 4:00 PM EDT
OrthoPediatrics Corp., tibbiy jihozlar ishlab chiqaruvchi kompaniya, AQSh va xalqaro miqyosda ortopedik kasalliklarga chalingan bolalar uchun anatomik jihatdan mos implantlar, asboblar va maxsus tayanchlarni loyihalash, ishlab chiqish va sotish bilan shug'ullanadi. Kompaniya bolalar travmalari va deformatsiyalarini tuzatish mahsulotlari; bolalarda umurtqa pog'onasi deformatsiyasini davolash uchun skolioz muolajalari; hamda sport tibbiyoti va boshqa mahsulotlarni taklif etadi. Uning mahsulotlari PediLoc, PediPlates, kanulyatsiya qilingan vintlar, PediFlex mixi, PediNail, PediLoc Tibia, ACL Rekonstruksiya tizimi, Blokirovkalangan Kanulyatsiya Blades, Blokirovkalangan Proksimal Son Suyagi, Spica Tables, RESPONSE Spine, BandLoc, Suyakning Pediatr Nail Platformasi, Devise Rail, Orthex, Fassier-Duval Teleskopik Intramedullariy tizimi, SLIM Nail, GAP Nail, Erkin Suyuvchi SCFE Vint tizimi, GIRO O'sish Modulyatsiya tizimi, PNP Tibia tizimi, ApiFix Mid-C tizimi, Mitchell Ponseti, VerteGlideTM va Boston Brace 3D ni o'z ichiga oladi. Kompaniya bolalar ortopediya bozoriga, shuningdek, bolalar ortoped jarrohlariga va parvarishlovchilarga xizmat ko'rsatadi. OrthoPediatrics Corp. 2006 yilda tashkil etilgan va V Warsaw, Indiana shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Daniel J. Gerritzen J.D. | Executive VP of Legal, General Counsel & Secretary |
| Mr. David R. Bailey | President, CEO & Director |
| Mr. Fred L. Hite | CFO, Principal Financial & Accounting Officer, COO and Director |
| Mr. Gregory A. Odle | President of Scoliosis |
| Mr. Joseph W. Hauser | President of Trauma, Deformity Correction & OPSB |
| Mr. Kevin L. Unger CHE, MBA/MSHA | President of Enabling Technologies |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-01 | 10-Q | kids-20260331.htm |
| 2026-04-30 | 8-K | kids-20260430.htm |
| 2026-04-20 | DEF 14A | kids-20260420.htm |
| 2026-04-01 | 8-K | tm2610693d1_8k.htm |
| 2026-03-04 | 10-K | kids-20251231.htm |
| 2026-02-26 | 8-K | kids-20260226.htm |
| 2026-01-12 | 8-K | kids-20260112.htm |
| 2025-10-29 | 10-Q | kids-20250930.htm |
| 2025-10-28 | 8-K | kids-20251028.htm |
| 2025-10-09 | 8-K | kids-20251009.htm |
| Mr. Mark Karshner | Senior Vice President of International Sales |
| Mr. Mark C. Throdahl | Executive Chairman |
| Ray Garrison | Senior Vice President of Quality & Regulatory and Clinical |